Roosa Kallionpää

1.2k total citations
18 papers, 284 citations indexed

About

Roosa Kallionpää is a scholar working on Anesthesiology and Pain Medicine, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Roosa Kallionpää has authored 18 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Anesthesiology and Pain Medicine, 7 papers in Cognitive Neuroscience and 4 papers in Oncology. Recurrent topics in Roosa Kallionpää's work include Anesthesia and Sedative Agents (8 papers), EEG and Brain-Computer Interfaces (4 papers) and Neural dynamics and brain function (3 papers). Roosa Kallionpää is often cited by papers focused on Anesthesia and Sedative Agents (8 papers), EEG and Brain-Computer Interfaces (4 papers) and Neural dynamics and brain function (3 papers). Roosa Kallionpää collaborates with scholars based in Finland, United States and Sweden. Roosa Kallionpää's co-authors include Antti Revonsuo, Harry Scheinin, Katja Valli, A Scheinin, Tero Vahlberg, Jaakko Långsjö, Kaike K. Kaisti, Anu Maksimow, George A. Mashour and Duan Li and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and International Journal of Cancer.

In The Last Decade

Roosa Kallionpää

17 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roosa Kallionpää Finland 10 146 112 44 44 34 18 284
Amber Y. Bo United States 8 55 0.4× 88 0.8× 130 3.0× 100 2.3× 13 0.4× 13 236
Katherine Baquero Belgium 5 114 0.8× 42 0.4× 23 0.5× 26 0.6× 26 0.8× 6 252
Ingobert Wenningmann Germany 10 50 0.3× 164 1.5× 56 1.3× 95 2.2× 34 1.0× 18 346
Joo‐Hyuk Im South Korea 10 28 0.2× 18 0.2× 9 0.2× 12 0.3× 320 9.4× 15 557
Zoeb Jiwaji United Kingdom 6 22 0.2× 7 0.1× 25 0.6× 62 1.4× 120 3.5× 10 328
Lorenzo Verriello Italy 12 30 0.2× 8 0.1× 11 0.3× 6 0.1× 151 4.4× 41 430
Sophie Hamelin France 9 50 0.3× 6 0.1× 8 0.2× 13 0.3× 118 3.5× 20 287
Sigmund Jenssen United States 8 111 0.8× 7 0.1× 8 0.2× 6 0.1× 115 3.4× 9 300
Szabolcs Dávid Netherlands 11 63 0.4× 6 0.1× 3 0.1× 8 0.2× 16 0.5× 26 254
C Kruse-Larsen Denmark 10 24 0.2× 14 0.1× 3 0.1× 19 0.4× 189 5.6× 13 332

Countries citing papers authored by Roosa Kallionpää

Since Specialization
Citations

This map shows the geographic impact of Roosa Kallionpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roosa Kallionpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roosa Kallionpää more than expected).

Fields of papers citing papers by Roosa Kallionpää

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roosa Kallionpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roosa Kallionpää. The network helps show where Roosa Kallionpää may publish in the future.

Co-authorship network of co-authors of Roosa Kallionpää

This figure shows the co-authorship network connecting the top 25 collaborators of Roosa Kallionpää. A scholar is included among the top collaborators of Roosa Kallionpää based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roosa Kallionpää. Roosa Kallionpää is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Wei, Arndt A. Schmitz, Roosa Kallionpää, et al.. (2024). Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland. Oncotarget. 15(1). 106–116. 2 indexed citations
2.
Kallionpää, Roosa, et al.. (2024). TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity. Genes and Immunity. 25(3). 188–200. 8 indexed citations
3.
4.
Schuller, Peter J., Cameron Casey, A Scheinin, et al.. (2024). The relationship of bispectral index values to conscious state: an analysis of two volunteer cohort studies. British Journal of Anaesthesia. 134(3). 727–735. 1 indexed citations
5.
Riihilä, Pilvi, et al.. (2024). Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma. International Journal of Cancer. 155(6). 1112–1127. 7 indexed citations
6.
Valli, Katja, Roosa Kallionpää, A Scheinin, et al.. (2023). Subjective experiences during dexmedetomidine- or propofol-induced unresponsiveness and non-rapid eye movement sleep in healthy male subjects. British Journal of Anaesthesia. 131(2). 348–359. 6 indexed citations
7.
Alkire, Michael T., A Scheinin, Jaakko Långsjö, et al.. (2023). Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine. Journal of Neuroscience. 43(26). 4884–4895. 11 indexed citations
8.
Jones, Amy V., Claire L. Harris, Tom Southerington, et al.. (2022). An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. PLoS ONE. 17(9). e0272260–e0272260. 3 indexed citations
9.
Kallionpää, Roope A., Roosa Kallionpää, Lauri Talve, et al.. (2022). Increased incidence of melanoma in children and adolescents in Finland in 1990–2014: nationwide re-evaluation of histopathological characteristics. Annals of Medicine. 54(1). 244–252. 13 indexed citations
10.
Laitio, Timo, Roosa Kallionpää, Jaakko Långsjö, et al.. (2021). Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome. European Journal of Anaesthesiology. 39(6). 521–532. 20 indexed citations
11.
Sandman, Nils, Roosa Kallionpää, A Scheinin, et al.. (2021). On no man’s land: Subjective experiences during unresponsive and responsive sedative states induced by four different anesthetic agents. Consciousness and Cognition. 96. 103239–103239. 3 indexed citations
12.
Scheinin, A, Michael T. Alkire, Jaakko Långsjö, et al.. (2020). Foundations of Human Consciousness: Imaging the Twilight Zone. Journal of Neuroscience. 41(8). 1769–1778. 41 indexed citations
13.
Kallionpää, Roosa, Katja Valli, A Scheinin, et al.. (2020). Alpha band frontal connectivity is a state-specific electroencephalographic correlate of unresponsiveness during exposure to dexmedetomidine and propofol. British Journal of Anaesthesia. 125(4). 518–528. 23 indexed citations
14.
Kallionpää, Roosa, Henri Pesonen, A Scheinin, et al.. (2019). Single-subject analysis of N400 event-related potential component with five different methods. International Journal of Psychophysiology. 144. 14–24. 14 indexed citations
15.
Långsjö, Jaakko, Timo Laitio, A Scheinin, et al.. (2018). Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on regional cerebral glucose metabolism in humans: a positron emission tomography study. British Journal of Anaesthesia. 121(1). 281–290. 35 indexed citations
16.
Kallionpää, Roosa, A Scheinin, Anu Maksimow, et al.. (2018). Dreaming and awareness during dexmedetomidine- and propofol-induced unresponsiveness. British Journal of Anaesthesia. 121(1). 260–269. 34 indexed citations
17.
Scheinin, A, Roosa Kallionpää, Duan Li, et al.. (2018). Differentiating Drug-related and State-related Effects of Dexmedetomidine and Propofol on the Electroencephalogram. Anesthesiology. 129(1). 22–36. 45 indexed citations
18.
Kallionpää, Roosa, A Scheinin, Roope A. Kallionpää, et al.. (2018). Spoken words are processed during dexmedetomidine-induced unresponsiveness. British Journal of Anaesthesia. 121(1). 270–280. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amber Y. Bo Breakdown of academic impact, for papers by Katherine Baquero Breakdown of academic impact, for papers by Ingobert Wenningmann Breakdown of academic impact, for papers by Joo‐Hyuk Im Breakdown of academic impact, for papers by Zoeb Jiwaji Breakdown of academic impact, for papers by Lorenzo Verriello Breakdown of academic impact, for papers by Sophie Hamelin Breakdown of academic impact, for papers by Sigmund Jenssen Breakdown of academic impact, for papers by Szabolcs Dávid Breakdown of academic impact, for papers by C Kruse-Larsen
Rankless by CCL
2026